Is age ≥ 70 years an important predictor of adverse events among patients enrolled in metastatic melanoma trials? Findings from pooled analyses of therapeutic trials

✍ Scribed by Aminah Jatoi; Jacob B. Allred; Vera J. Suman; Edward T. Creagan; Gary A. Croghan; Thomas Amatruda; Svetomir N. Markovic

• Book ID: 119297521
• Publisher: Elsevier
• Year: 2012
• Tongue: English
• Weight: 293 KB
• Volume: 3
• Category: Article
• ISSN: 1879-4068
• DOI: 10.1016/j.jgo.2012.04.002